The Use of Botulinum Toxin for Treatment of Acquired Nystagmus and Oscillopsia

Ophthalmology ◽  
1994 ◽  
Vol 101 (4) ◽  
pp. 783-787 ◽  
Author(s):  
Simon T. Ruben ◽  
John P. Lee ◽  
Damian O'Neil ◽  
Iain Dunlop ◽  
John S. Elston
Keyword(s):  
Botulinum Toxin ◽  
Acquired Nystagmus

Unsatisfactory Treatment of Acquired Nystagmus With Retrobulbar Injection of Botulinum Toxin

1995 ◽  
Vol 119 (4) ◽  
pp. 489-496 ◽  
Author(s):  
ROBERT L. TOMSAK ◽  
BERND F. REMLER ◽  
LEA AVERBUCH-HELLER ◽  
MOHAN CHANDRAN ◽  
R. JOHN LEIGH
Keyword(s):  
Botulinum Toxin ◽  
Acquired Nystagmus

Effectiveness of botulinum toxin administered to abolish acquired nystagmus

1992 ◽  
Vol 32 (5) ◽  
pp. 633-642 ◽  
Author(s):  
R. John Leigh ◽  
Robert L Tomsak ◽  
Michael P. Grant ◽  
Bernd F. Remler ◽  
Stacy S. Yaniglos ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Acquired Nystagmus

The Use of Botulinum Toxin for Treatment of Acquired Nystagmus and Oscillopsia

1994 ◽  
Vol 14 (4) ◽  
pp. 223
Author(s):  
Ruben ST ◽  
Lee JP ◽  
O??Neil D ◽  
Dunlop I ◽  
Elston JS
Keyword(s):  
Botulinum Toxin ◽  
Acquired Nystagmus

scholarly journals Unsatisfactory Treatment of Acquired Nystagmus With Retrobulbar Injection of Botulinum Toxin

1996 ◽  
Vol 16 (1) ◽  
pp. 62
Author(s):  
R L Tomsak ◽  
B F Remler ◽  
L Averbuch-Heller ◽  
M Chandran ◽  
R J Leigh
Keyword(s):  
Botulinum Toxin ◽  
Acquired Nystagmus

Severe Drooling and Treatment With Botulinum Toxin

2012 ◽  
Vol 21 (1) ◽  
pp. 15-21
Author(s):  
Merete Bakke ◽  
Allan Bardow ◽  
Eigild Møller
Keyword(s):  
Botulinum Toxin ◽  
Side Effects ◽  
Health Risk ◽  
Flow Rate ◽  
Clinical Evidence ◽  
Acetylcholine Release ◽  
Psychosocial Problems ◽  
Rate Reduction ◽  
Local Inhibition ◽  
Surgical Treatments

Severe drooling is associated with discomfort and psychosocial problems and may constitute a health risk. A variety of different surgical and non-surgical treatments have been used to diminish drooling, some of them with little or uncertain effect and others more effective but irreversible or with side effects. Based on clinical evidence, injection with botulinum toxin (BTX) into the parotid and submandibular glands is a useful treatment option, because it is local, reversible, and with few side effects, although it has to be repeated. The mechanism of BTX is a local inhibition of acetylcholine release, which diminishes receptor-coupled secretion and results in a flow rate reduction of 25–50% for 2–7 months.

Sign in / Sign up

Export Citation Format

Share Document